Extracellular ATP induces P2X7-dependent nicotinamide phosphoribosyltransferase release in LPS-activated human monocytes

Innate Immunity

Volumn 18, Issue 5, 2012, Pages 738-744

  Schilling, Erik ^a   Hauschildt, Sunna ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

ATP; LPS; Monocyte; NAMPT; P2X7 receptor

Indexed keywords

ADENOSINE TRIPHOSPHATE; APYRASE; HEXOKINASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PURINERGIC P2X7 RECEPTOR;

ARTICLE; CELL MEMBRANE PERMEABILITY; CONCENTRATION (PARAMETERS); CYTOTOXICITY; ENZYME RELEASE; HUMAN; HUMAN CELL; HYDROLYSIS; MONOCYTE;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ADENOSINE TRIPHOSPHATE; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; CYTOKINES; EXTRACELLULAR SPACE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LIPOPOLYSACCHARIDES; MONOCYTES; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RECEPTORS, PURINERGIC P2X7; SIGNAL TRANSDUCTION;

EID: 84867092344     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425912439614     Document Type: Article

References (36)

1. Corda D, Di Girolamo M. Functional aspects of protein mono-ADP-ribosylation. EMBO J. 2003 ; 22: 1953-1958
2. Burkle A. Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays. 2001 ; 23: 795-806
3. Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J. 2007 ; 404: 1-13
4. Magni G, Amici A, Emanuelli M, et al. Enzymology of NAD+ synthesis. Adv Enzymol Relat Areas Mol Biol. 1999 ; 73: 135-82, xi
5. Luk T, Malam Z, Marshall JC. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol. 2008 ; 83: 804-816
6. Schilling E, Wehrhahn J, Klein C, et al. Inhibition of nicotinamide phosphoribosyltransferase modifies lipopolysaccharide-induced inflammatory responses of human monocytes. Innate Immun 2011. Epub ahead of print. DOI: 10.1177/1753425911423853.
7. Moschen AR, Kaser A, Enrich B, et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol. 2007 ; 178: 1748-1758
8. Li Y, Zhang Y, Dorweiler B, et al. Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism. J Biol Chem. 2008 ; 283: 34833-34843
9. Jia SH, Li Y, Parodo J, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest. 2004 ; 113: 1318-1327
10. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005 ; 307: 426-430
11. Ye SQ, Simon BA, Maloney JP, et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med. 2005 ; 171: 361-370
12. Dahl TB, Yndestad A, Skjelland M, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation. 2007 ; 115: 972-980
13. Brentano F, Schorr O, Ospelt C, et al. Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. Arthritis Rheum. 2007 ; 56: 2829-2839
14. Rongvaux A, Shea RJ, Mulks MH, et al. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur J Immunol. 2002 ; 32: 3225-3234
15. Revollo JR, Korner A, Mills KF, et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 2007 ; 6: 363-375
16. Perregaux DG, Bhavsar K, Contillo L, et al. Antimicrobial peptides initiate IL-1 beta posttranslational processing: a novel role beyond innate immunity. J Immunol. 2002 ; 168: 3024-3032
17. Grahnert A, Klein C, Hauschildt S. Involvement of P2X receptors in the NAD(+)-induced rise in [Ca (2+)] (i) in human monocytes. Purinergic Signal. 2009 ; 5: 309-319
18. Gabel CA. P2 purinergic receptor modulation of cytokine production. Purinergic Signal. 2007 ; 3: 27-38
19. Perregaux DG, McNiff P, Laliberte R, et al. ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J Immunol. 2000 ; 165: 4615-4623
20. Ferrari D, Chiozzi P, Falzoni S, et al. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol. 1997 ; 159: 1451-1458
21. Sluyter R, Shemon AN, Wiley JS. Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes. J Immunol. 2004 ; 172: 3399-3405
22. Lambrecht G, Friebe T, Grimm U, et al. PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. Eur J Pharmacol. 1992 ; 217: 217-219
23. Bianchi BR, Lynch KJ, Touma E, et al. Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol. 1999 ; 376: 127-138
24. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998 ; 50: 413-492
25. North RA, Surprenant A. Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol. 2000 ; 40: 563-580
26. Murgia M, Hanau S, Pizzo P, et al. Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J Biol Chem. 1993 ; 268: 8199-8203
27. Humphreys BD, Virginio C, Surprenant A, et al. Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Mol Pharmacol. 1998 ; 54: 22-32
28. Rassendren F, Buell GN, Virginio C, et al. The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J Biol Chem. 1997 ; 272: 5482-5486
29. Surprenant A, Rassendren F, Kawashima E, et al. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science. 1996 ; 272: 735-758
30. Gerth A, Nieber K, Oppenheimer NJ, Hauschildt S. Extracellular NAD+ regulates intracellular free calcium concentration in human monocytes. Biochem J. 2004 ; 382: 849-856
31. Steinberg TH, Silverstein SC. Extracellular ATP4- promotes cation fluxes in the J774 mouse macrophage cell line. J Biol Chem. 1987 ; 262: 3118-3122
32. Perregaux D, Gabel CA. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem. 1994 ; 269: 15195-15203
33. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995 ; 376: 37-43
34. Walev I, Reske K, Palmer M, et al. Potassium-inhibited processing of IL-1 beta in human monocytes. EMBO J. 1995 ; 14: 1607-1614
35. Ferrari D, Chiozzi P, Falzoni S, et al. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J Exp Med. 1997 ; 185: 579-582
36. Di Virgilio F. Novel data point to a broader mechanism of action of oxidized ATP: the P2X7 receptor is not the only target. Br J Pharmacol. 2003 ; 140: 441-443